Rotem-Wildeman Karin
- SEC CIK
- 0001959299
No open-market purchases or sales filed in the past year.
Current role at each company
- KDP Keurig Dr Pepper Inc.Chief R&D Officeras of Mar 11, 2024
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Rotem-Wildeman Karin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 11, 2024 (view filing) | Mar 7 | 4 days | Rotem-Wildeman KarinChief R&D Officer | PPurchase | +4.08K | $29.11 | +$118.6K | +5.9%73.5K after | |
| Oct 30, 2023 (view filing) | Oct 27 | 3 days | Rotem-Wildeman KarinChief R&D Officer | PPurchase | +7.05K | $29.95 | +$211.1K | +11.3%69.4K after | |
| Aug 4, 2023 (view filing) | May 4-Aug 3 | 92 daysLate | Rotem-Wildeman KarinChief R&D Officer | PPurchase | +53.8K | $34.30 | +$1.85M | +628.9%62.4K after | 3 lots |
| May 5, 2023 (view filing) | May 4 | 1 day | Rotem-Wildeman KarinChief R&D Officer | PPurchase | +8.56K | $32.35 | +$276.9K | +42.4%28.7K after | |
| Mar 16, 2023 (view filing) | Mar 14-15 | 2 days | Rotem-Wildeman KarinChief R&D Officer | PPurchase | +20.2K | $34.53 | +$696.5K | New position20.2K after | 2 lots |